Business Wire

Mary Kay Inc. Champions Business Excellence, Ethics and Social Responsibility in Direct Selling Sector and Beauty Industry, Reaps Rewards in Europe

10.7.2019 10:00:00 EEST | Business Wire | Press release

Share

On May 22, the global beauty company announced Chairman and CEO David Holl is among the top ten most reputable chief executives in the world according to Reputation Institute’s 2019 CEO RepTrak® study. Reputation Institute, the world’s leading provider of reputation intelligence, measured the reputation of more than 140 global CEOs and canvassed more than 230,000 individual ratings among the informed public. The study was conducted in January and February of this year.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190710005268/en/

To view this piece of content from mms.businesswire.com, please give your consent at the top of this page.

Tara Eustace, President of the Mary Kay Europe Region. (Photo: Mary Kay Inc.)

According to Kylie Wright-Ford, CEO at Reputation Institute, acting responsibly, behaving ethically and caring about social issues are the most important drivers of CEO reputation. In fact, according to Reputation Institute’s findings, CEOs are more likely to be judged on ethics versus profit margins. In this way, the perception of CEOs and the companies they lead are directly correlated.

This meaningful recognition echoes the series of milestones reached by Mary Kay in Europe over the past months. In 2018 and 2019, Mary Kay's Europe Region earned over 90 product and industry awards and counting — a testament to Mary Kay’s mission to enrich women’s lives, offer science-driven products women love and a long-standing commitment to give back to the community.

“In a highly competitive environment, Mary Kay’s business values stand out around the world, and shine in Europe,” said Tara Eustace, President of the Mary Kay Europe Region. “Each of these awards materialize the truth of our commitment; they also provide Independent Beauty Consultants in Europe pride to celebrate with their customers and share product news and updates, while reinforcing confidence in the brand,” added Eustace.

Recent awards include:

Excellence in Direct Selling
Seldia, the European Direct Selling Association, recently recognized Mary Kay Europe as “Best Company of the Year” at its 2018 Astra Awards. In July 2019, Mary Kay Belarus received the “Direct Sales Cosmetic Company Number One Award” from the “Number One” annual national awards. In June 2019, Mary Kay Ukraine was recognized as “Number 1 Direct Selling Cosmetic Brand” in the “Favor of Success” survey. Mary Kay Spain has been the 2014, 2015, 2016 and 2017 “Number 1 Direct Selling Cosmetic Company” according to the Commercial Register data.

Excellence in Women’s Leadership
In April 2019, Mary Kay Russia’s General Manager, Alla Sokolova, received the "Manager of the Year Award” from Russian Business Guide's People of the Year, recognizing her contribution to the development of the Russian economy and entrepreneurship in Russia.

In 2016, 2017, and 2018, Mary Kay Spain's General Manager, Gema Aznar, was featured in YoDona magazine's annual “500 Most Influential Women in Spain” list highlighted in its special edition called “Female Power.”

Excellence in Women’s Entrepreneurship and Empowerment
On May 24, the “Secrets of Big Business with Mary Kay®” program created by Mary Kay Russia was recognized as the “2019 Best Social Project of Russia Award” in the “Social Entrepreneurship” category. In November 2018, Mary Kay Russia had already earned the “Woman Who Matters Award” rewarding women’s entrepreneurship for the “Secrets of Big Business with Mary Kay®” program. “Woman Who Matters” identifies the best initiatives, practices and programs of Russian companies aimed at women’s support.

Mary Kay Russia also received the “2018 Best Social Project of Russia Award” for its “Beauty of Confidence” campaign and Skin Care Labs. The Best Russian Social Project annual contest was held in May, with more than 70 companies submitting their social projects. The program was created to support the Russian government’s plans to strengthen social policies.

Mary Kay Belarus received a “2018 Brand of the Year” Silver Medal in the Social Responsibility category for its socially active position. The award was a result of the implementation of the “Beauty That Counts” program and the company's contribution to the development of women's entrepreneurship in Belarus.

Mary Kay UK received the “Company with Heart Award” at the 2018 UK Pride of Direct Selling Awards for their partnership with the Look Good, Feel Better charity. “The Company with Heart Award” is awarded to the company which has gone the extra mile to make a charitable impact through its philanthropic activities and community engagement work.

Excellence in Digital Training
Mary Kay was recognized in the “2019 Spring Omni Awards” with a coveted gold ranking in the Educational category for its innovative Link & Learn™ sales education system. The e-learning platform hosts a robust learning curriculum designed to amplify educational support for the independent sales force and increase their business success. It also connects Mary Kay Independent Beauty Consultants to a learning community based on content, accessibility and localization. Mary Kay’s Link & Learn was also awarded a “2018 Technology Excellence Award” from the Brandon Hall Group last January with a Bronze Medal in the category of Best Advance in Learning Management Technology for External Training.

Excellence in Digital & Printed Tools
In April, Mary Kay Russia’s MirrorMe App won the "2019 Best Corporate Media Award” in the "Client Media: Web Media” category. With the Mary Kay® MirrorMe mobile application, anyone can create beautiful makeup without any makeup tools.

Mary Kay Russia’s “Applause” magazine for Independent Beauty Consultants won two awards in 2018: the "Media Leader Award” in the category "Best Corporate Magazine" and the “Silver Threads Award” in the category “Best Corporate Edition.”

Excellence as an Employer
Mary Kay Spain and Mary Kay Poland earned the “2018 AON Best Employers Award,” recognizing organizations demonstrating excellence in the workplace.

Product Excellence
With more than 1,500 patents and a team of scientists dedicated to producing innovative products backed by proven results, Mary Kay® products garnered more than 40 awards in 2018 and already 22 in 2019. Among the products distinguished by the Beauty industry and consumers, Mary Kay TimeWise Miracle® 3D set, TimeWise Repair® Lifting Bio-Cellulose Mask, TimeWise® Vitamin C Activating Squares, and Oil-Free Eye Makeup Remover, were the most rewarded.

About Mary Kay
One of the original glass ceiling breakers, Mary Kay Ash founded her beauty company more than 55 years ago with three goals: offer rewarding opportunities for women, manufacture irresistible products and make the world a better place. That dream has blossomed into a multibillion-dollar company with millions of independent sales force members in nearly 40 countries. Mary Kay is dedicated to researching the science behind beauty and to manufacturing cutting-edge skin care, color cosmetics, fragrances and nutritional supplements. Through the Mary Kay Foundation℠, the company has awarded more than $78 million to cancer research and domestic violence shelters. Mary Kay Ash’s original vision continues to shine—one lipstick at a time.

About Reputation Institute
Reputation Institute helps leaders at the world’s largest companies build credibility with the people that matter most to them by delivering data-driven insights about how they are truly perceived. We do this with RepTrak®, an unrivaled technology that provides actionable insights across industry, competitor, and company analysis. Past and present clients have included Whirlpool, Barnes & Noble,​The Estée Lauder Companies, ​JP Morgan Chase & Co., LEGO, P&G, Cisco, and Telefonica, among many others.

About Seldia
Seldia recognizes the outstanding achievements of organizations that demonstrate excellence in empowerment, entrepreneurship and a commitment to producing best-in-the-industry products. Representing 28 national direct selling associations and 20 member-companies throughout Europe, Seldia’s mission is to promote the interest of national direct selling associations and direct selling companies in the European footprint. “Best Company of the Year” recognizes the corporate member that best raises awareness of the direct selling method of distribution, promotes the method’s socio-economic benefits and demonstrates a strong commitment to supporting the mission of Seldia.

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Contact information

Mary Kay Inc. Corporate Communications
marykay.com/newsroom
972.687.5332 or media@mkcorp.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 11:00:00 EEST | Press release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 18:15:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 13:00:00 EEST | Press release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

Charlotte Tilbury awarded CBE in the King’s Birthday Honours 202613.6.2026 00:31:00 EEST | Press release

Charlotte Tilbury CBE, sole Founder, President, Chairman and Chief Creative Officer of Charlotte Tilbury Beauty, has been awarded a Commander of the Order of the British Empire (CBE) in the King’s Birthday Honours 2026 for services to the beauty and cosmetics industry. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612679101/en/ Charlotte Tilbury, founder, president, chairman and chief creative officer of Charlotte Tilbury Beauty, who has been awarded a CBE (Commander of the Order of the British Empire) in 2026 for services to the beauty industry and entrepreneurship. (Photo: Charlotte Tilbury team) This honour recognises Charlotte’s contribution to leading and building Britain’s most successful global beauty brand. She has played a defining role in revolutionising the beauty industry and driving economic growth of the UK beauty sector, which has expanded from approximately £17bn in 2013 to over £31bn today. Charlotte Til

IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors12.6.2026 19:36:00 EEST | Press release

IQM Quantum Computers, the global leader in superconducting quantum computers, today announced the appointment of Barbara Venneman to its Board of Directors. Venneman deepens the Board's expertise in digital transformation, enterprise technology commercialization, and global business scaling as IQM expands its commercial footprint worldwide. Additionally, CEO and Co-founder Jan Goetz will replace Co-founder Juha Vartiainen as the Founder representative on the IQM Board. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260612650938/en/ IQM Appoints Barbara Venneman, Vanguard Board Director and Former Global Head of Deloitte Digital, to its Board of Directors Ms. Venneman joins the IQM Board of Directors following a distinguished career at the intersection of advanced technology, strategy, and business transformation. She most recently served as Global Head of Deloitte Digital and previously held senior global leadership roles,

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye